中文版 | English
Title

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation

Author
Corresponding AuthorYang, Lin; Ma, Nan
Publication Years
2023-02-01
DOI
Source Title
ISSN
1936-5233
Volume28
Abstract
HCC is a highly lethal tumor, and orthotopic liver transplantation, as one of the radical treatment methods for HCC, has opened-up a new therapeutic approach for the treatment of primary liver cancer. However, tumor recurrence after liver transplantation is the main reason that affects the long-term survival of recipients. At present, the application of ICIs has brought dawn to patients with refractory HCC. However, because of the special immune tolerance state created by long-term oral immunosuppressants in patients with HCC after liver transplantation, the current focus is how to regulate the immune balance of such patients and simultaneously maximize the anti-tumor effect. This article reviews the relationship between liver cancer and immunity, im-mune tolerance of liver transplantation, immune microenvironment after liver transplantation for HCC, and the application of immunotherapy in the recurrence of liver transplantation for HCC.
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
First ; Corresponding
Funding Project
null[SZXK079]
WOS Research Area
Oncology
WOS Subject
Oncology
WOS Accession No
WOS:000911260300001
Publisher
Data Source
Web of Science
Citation statistics
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/583150
DepartmentThe Third People's Hospital of Shenzhen
南方科技大学第一附属医院
Affiliation
1.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Div Liver Surg, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 2, 29 Bulan Rd, Shenzhen 518112, Guangdong, Peoples R China
2.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Organ Transplantat Ctr, Natl Clin Res Ctr Infect Dis,Affiliated Hosp 2, 29 Bulan Rd, Shenzhen 518112, Guangdong, Peoples R China
3.Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Med Oncol,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
First Author AffilicationThe Third People's Hospital of Shenzhen;  Shenzhen People's Hospital
Corresponding Author AffilicationThe Third People's Hospital of Shenzhen;  Shenzhen People's Hospital
First Author's First AffilicationThe Third People's Hospital of Shenzhen;  Shenzhen People's Hospital
Recommended Citation
GB/T 7714
Jin, Xin,Ma, Xiaoting,Zhao, Dong,et al. Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation[J]. TRANSLATIONAL ONCOLOGY,2023,28.
APA
Jin, Xin,Ma, Xiaoting,Zhao, Dong,Yang, Lin,&Ma, Nan.(2023).Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation.TRANSLATIONAL ONCOLOGY,28.
MLA
Jin, Xin,et al."Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation".TRANSLATIONAL ONCOLOGY 28(2023).
Files in This Item:
There are no files associated with this item.
Related Services
Fulltext link
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Jin, Xin]'s Articles
[Ma, Xiaoting]'s Articles
[Zhao, Dong]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Jin, Xin]'s Articles
[Ma, Xiaoting]'s Articles
[Zhao, Dong]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Jin, Xin]'s Articles
[Ma, Xiaoting]'s Articles
[Zhao, Dong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.